University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy
A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the efficacy of chimeric antigen receptor T-cell…
News
Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches
Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™
Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research and clinical trials are essential in supporting…
SABI Annual Meeting 2023
Innovation towards professional, financial, and environmental sustainability.
Study Highlights the Potential of Radiomics in Medical Intervention
A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy (RCT) on patients with Head and Neck Squamous Cell…